Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 23 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 1 day agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 2 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
Willner & Heller LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoWillner & Heller LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 19,822 shares of the biopharmaceutical ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 7 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Livelsberger Financial Advisory Acquires Shares of 4,103 Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoLivelsberger Financial Advisory bought a new position in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to its most recent 13F filing with ...
Gateway - Quartz
Quartz· 15 hours agoThe company announced on Oct. 20 that it intends to sell the covid vaccine, marketed under the brand name Comirnaty, for $110 to $130 per dose. According to The People’s & ...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 7 hours agoNot only have its results become more sharply partisan, favoring Republican and conservative...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 6 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...